Search Results - "Bhatnagar, Namrata"
-
1
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Published in Cancer cell (10-07-2012)“…The ALKF1174L mutation is associated with intrinsic and acquired resistance to crizotinib and cosegregates with MYCN in neuroblastoma. In this study, we…”
Get full text
Journal Article -
2
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma
Published in Cancer cell (10-07-2012)“…The ALK(F1174L) mutation is associated with intrinsic and acquired resistance to crizotinib and cosegregates with MYCN in neuroblastoma. In this study, we…”
Get full text
Journal Article -
3
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma
Published in Oncotarget (30-09-2014)“…Mutations in the ALK tyrosine kinase receptor gene represent important therapeutic targets in neuroblastoma, yet their clinical translation has been…”
Get full text
Journal Article -
4
3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin
Published in Cancer prevention research (Philadelphia, Pa.) (01-06-2009)“…Butyrate is an inhibitor of histone deacetylase (HDAC) and has been extensively evaluated as a chemoprevention agent for colon cancer. We recently showed that…”
Get full text
Journal Article -
5
Abstract 4454: The AXL tyrosine kinase receptor contributes to ALK-inhibitor resistance in neuroblastoma
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Abstract The crizotinib-resistant ALKF1174L mutation occurs de novo in neuroblastoma (NB) and as an acquired mechanism of resistance in ALK…”
Get full text
Journal Article -
6
Mutations that disrupt PHOXB interaction with the neuronal calcium sensor HPCAL1 impede cellular differentiation in neuroblastoma
Published in Oncogene (19-06-2014)“…Heterozygous germline mutations in PHOX2B , a transcriptional regulator of sympathetic neuronal differentiation, predispose to diseases of the sympathetic…”
Get full text
Journal Article -
7
Abstract 2935: The ATP-competitive mTOR inhibitor Torin2 enhances sensitivity of the ALK F1174L mutation to crizotinib in neuroblastoma
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Abstract Mutations in the anaplastic lymphoma kinase (ALK) receptor represent an important therapeutic target in neuroblastoma. The most frequently occurring…”
Get full text
Journal Article -
8
3,3′‐Diindolylmethane Enhances the Efficacy of Butyrate in Colon Cancer Prevention through Down‐regulation of Survivin
Published in The FASEB journal (01-04-2009)“…Abstract only Butyrate is an inhibitor of histone deacetylase (HDAC) and has been extensively evaluated as a chemoprevention agent for colon cancer. We…”
Get full text
Journal Article -
9
Regulation of prostate cancer apoptosis and response to chemotherapy by miR-205 and miR-31
Published 01-01-2010“…Prostate cancer is the most common form of cancer amongst men in the United States and ranks second in being the major leading cause of death due to cancer in…”
Get full text
Dissertation